7-Chloro-5-methyl-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidine, 95.0%, 1g

1,3-Bis(bromomethyl)benzene, 97.0%, 25g

(2E)-1-(3-bromophenyl)-3-(4-bromophenyl)prop-2-en-1-one, 95.0%, 10g

N-(1H-1,2,3-Benzotriazol-1-ylmethyl)-N-ethylaniline, 98.0%, 250mg

TMS-HT Kit (=HMDS and TMCS in Anhydrous Pyridine) 1 mL * 8 / Reaction vial, capacity 2 mL * 8 [Trimethylsilylating Reagent, for OH compounds]1kit

4,7-Dichlorothieno[2,3-d]pyridazine, 95.0%, 10g

3,5-Dichloro-4-fluorophenol, 98%, 250mg

1,1,3,5,5-Pentaphenyl-1,3,5-trimethyltrisiloxane, 100g

5-Bromo-N-(diphenylmethylene)-2-pyrimidinamine, 95+%, 1g

(S)-3-Bromo-6-((tert-butyldimethylsilyl)oxy)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine, 98%, 250mg

Methyl chroman-3-carboxylate, 96%, 1g

2'-Methoxy-2,2,2-trifluoroacetophenone, 97.0%, 25g